Long-term patient-reported outcomes from monarchE: Abemaciclib plus endocrine therapy as adjuvant therapy for HR+, HER2-, node-positive, high-risk, early breast cancer

  1. Tolaney, S.M.
  2. Guarneri, V.
  3. Seo, J.H.
  4. Cruz, J.
  5. Abreu, M.H.
  6. Takahashi, M.
  7. Barrios, C.
  8. McIntyre, K.
  9. Wei, R.
  10. Munoz, M.
  11. Antonio, B.S.
  12. Liepa, A.M.
  13. Martin, M.
  14. Johnston, S.R.D.
  15. Kellokumpu-Lehtinen, P.-L.
  16. Harbeck, N.
Aldizkaria:
European Journal of Cancer

ISSN: 1879-0852,  0959-8049

Argitalpen urtea: 2024

Alea: 199

Mota: Artikulua

DOI: 10.1016/J.EJCA.2024.113555 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus